167 related articles for article (PubMed ID: 32664931)
21. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
[TBL] [Abstract][Full Text] [Related]
22. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
23. Access to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: qualitative findings from health navigators with the iDU ("I do") Care Collaborative.
Stopka TJ; Hutcheson M; Donahue A
Harm Reduct J; 2017 May; 14(1):26. PubMed ID: 28521814
[TBL] [Abstract][Full Text] [Related]
24. Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15.
Glass R; Hope VD; Njoroge J; Edmundson C; Smith J; McVeigh J; Parry J; Desai M
Drug Alcohol Depend; 2019 Feb; 195():40-44. PubMed ID: 30580202
[TBL] [Abstract][Full Text] [Related]
25. A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs.
Värmå Falk M; Strömdahl S; Ekström AM; Kåberg M; Karlsson N; Dahlborn H; Hammarberg A
Harm Reduct J; 2020 Oct; 17(1):84. PubMed ID: 33092595
[TBL] [Abstract][Full Text] [Related]
26. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
O'Keefe D; Aitken C; Scott N; Dietze P
Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
[TBL] [Abstract][Full Text] [Related]
27. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment.
Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R
BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365
[TBL] [Abstract][Full Text] [Related]
28. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
29. Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia.
Islam MM; Topp L; Conigrave KM; White A; Haber PS; Day CA
Int J Drug Policy; 2013 Jul; 24(4):326-32. PubMed ID: 22818978
[TBL] [Abstract][Full Text] [Related]
30. Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.
Noroozi M; Marshall BDL; Noroozi A; Armoon B; Sharifi H; Farhoudian A; Ghiasvand H; Vameghi M; Rezaei O; Sayadnasiri M; Pouya RH
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S303-S308. PubMed ID: 29271013
[TBL] [Abstract][Full Text] [Related]
31. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
Syvertsen JL; Pollini RA
Int J Drug Policy; 2020 Jan; 75():102594. PubMed ID: 31775079
[TBL] [Abstract][Full Text] [Related]
32. Hospital admissions among people who inject opioids following syringe services program implementation.
Bornstein KJ; Coye AE; St Onge JE; Li H; Muller A; Bartholomew TS; Tookes HE
Harm Reduct J; 2020 May; 17(1):30. PubMed ID: 32398059
[TBL] [Abstract][Full Text] [Related]
33. Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.
Deryabina A; El-Sadr WM
Drug Alcohol Depend; 2017 Oct; 179():180-186. PubMed ID: 28787695
[TBL] [Abstract][Full Text] [Related]
34. Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore's Experience.
Heidari O; Meyer D; Lowensen K; Patil A; O'Conor KJ; LaRicci J; Hunt D; Bocek AP; Cargill V; Farley JE
Health Aff (Millwood); 2024 Jun; 43(6):883-891. PubMed ID: 38830163
[TBL] [Abstract][Full Text] [Related]
35. Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs.
Brooks HL; O'Brien DC; Salvalaggio G; Dong K; Hyshka E
Drug Alcohol Rev; 2019 May; 38(4):423-427. PubMed ID: 31021491
[TBL] [Abstract][Full Text] [Related]
36. Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007-2015.
Jacka B; Kemp R; Degenhardt L; Peacock A; Clare P; Bruno R; Dev A; Sotade O; Larance B
Drug Alcohol Rev; 2019 Feb; 38(2):159-168. PubMed ID: 30761653
[TBL] [Abstract][Full Text] [Related]
37. Police officer attitudes towards syringe services programming.
Sightes E; Ray B; Paquet SR; Bailey K; Huynh P; Weintraut M
Drug Alcohol Depend; 2019 Dec; 205():107617. PubMed ID: 31707271
[TBL] [Abstract][Full Text] [Related]
38. Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care.
López-Castro T; Sohler N; Riback L; Bravo G; Ohlendorf E; Ghiroli M; Fox AD
Harm Reduct J; 2024 Jun; 21(1):108. PubMed ID: 38824597
[TBL] [Abstract][Full Text] [Related]
39. The risk environments of people who use drugs accessing two harm reduction centers in Tehran, Iran: A qualitative study.
Bastani P; Marshall BDL; Rahimi-Movaghar A; Noroozi A
Int J Drug Policy; 2019 Jan; 63():90-96. PubMed ID: 30513474
[TBL] [Abstract][Full Text] [Related]
40. Qualitative evaluation of a peer-based needle syringe programme in Vietnam.
Ngo AD; Schmich L; Higgs P; Fischer A
Int J Drug Policy; 2009 Mar; 20(2):179-82. PubMed ID: 18242971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
